Formulation & Delivery Science
We engineer delivery systems to improve absorption, stability, and performance of finished dosage forms, particularly for lipophilic and complex actives.
From formulation design and delivery technologies to GMP manufacturing and scale-up, we support the full lifecycle of regulated pharmaceutical and nutraceutical products.
We engineer delivery systems to improve absorption, stability, and performance of finished dosage forms, particularly for lipophilic and complex actives.
Our CDMO model combines formulation development, pharmaceutical-grade ingredient sourcing, and GMP manufacturing to support reliable scale-up and commercialization.
Processes, documentation, and quality systems are designed to meet the requirements of pharmaceutical and nutraceutical regulatory pathways.
The gut-friendly delivery platform improves bioavailability, ensures stability, and supports controlled release across diverse actives.
Three divisions, one mission: Pharmaceuticals, delivering evidence-based prescription therapies; Nutraceuticals, powered by QuanticSphere™ for enhanced bioavailability and superior tolerance; and Cosmeceuticals, offering science-driven innovations for skin, hair, and overall beauty wellness.
Evidence-based Rx molecules and combinations designed for lipid control, glycemia, inflammation, pain and cardiovascular risk—integrated with monitoring and adherence.
QuanticSphere™ enabled formulations that achieve higher plasma exposure at lower doses—engineered for gut-friendly, sustained benefit.
Next-generation delivery engineered for higher bioavailability and consistent, gut-friendly performance.
Clinically demonstrated to achieve greater plasma exposure than widely used forms
Joint health solution—16 synergistic actives encapsulated in phospholipid nano-spheres for 85–90% uptake and >90% stability.
Highly purified EPA for triglyceride reduction and CV risk lowering in select high-risk patients as an adjunct to statin therapy.
Supports healthy aging with NAD+ boosting, antioxidant defense, and clinically backed cellular repair.
Updates from research, partnerships, and our communities.
From formulation to scale—CDMO engagements leveraging PQNS and our capsule/softgel platforms.
Explore open roles in R&D, manufacturing, clinical affairs, and more.
